Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Test can detect HIV resistance before viral load increase

This article was originally published in Clinica

Executive Summary

ViroLogic has released data that show that its PhenoSense HIV phenotypic resistance assay can detect the emergence of viral drug resistance in HIV patients before a significant increase in the viral load is apparent. This is the first time that this has been demonstrated, ViroLogic says, and may have important implications for the management of patients receiving antiretroviral therapy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069509

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel